Petr Libánský1, Svatopluk Adámek1, Petr Broulík2, Martina Fialová1, Josef Kubinyi3, Robert Lischke1, Ondřej Naňka4, Pavel Pafko1, Jiří Šedý5, Vladimír Bobek6,7,8,9. 1. Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. 2. Third Department of Medicine, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. 3. Institute of Nuclear Medicine, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. 4. Institute of Anatomy, First Faculty of Medicine, Charles University, Prague, Czech Republic. 5. Department of Anatomy, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic. 6. Third Department of Surgery, First Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic vbobek@centrum.cz. 7. Department of Laboratory Genetics, University Hospital Kralovske Vinohrady, Prague, Czech Republic. 8. Department of Thoracic Surgery, Masaryk's Hospital in Usti nad Labem, Labem, Czech Republic. 9. Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland.
Abstract
BACKGROUND/AIM: Parathyroid carcinoma is a rare clinical entity, which represents one of the main reasons, why surgery should be performed in specialized centres. Preoperatively, it is very difficult to distinguish between benign and malignant hyperparathyroidism. PATIENTS AND METHODS: During the years 1996-2016, we performed 2,220 operations in 2,075 patients with a diagnosis of primary hyperparathyroidism. RESULTS: Among these 2,220 operations, there were 16 operations for parathyroid carcinoma. These 16 operations, including reoperations, were performed in four patients. Two patients had no reoperation, but another 2 patients required 14 reoperations in total. Parathyroid carcinoma was described in 0.2% of all patients with a diagnosis of primary hyperparathyroidism. The number of operations was 0.73% of all operations of primary hyperparathyroidism in years 1996-2016. CONCLUSION: Prognosis of parathyroid carcinoma is quite favourable, patients evidence a long-term survival rate after the primary operation. However, every reoperation increases the number of possible complications, including recurrent laryngeal nerve injury. Copyright
BACKGROUND/AIM: Parathyroid carcinoma is a rare clinical entity, which represents one of the main reasons, why surgery should be performed in specialized centres. Preoperatively, it is very difficult to distinguish between benign and malignant hyperparathyroidism. PATIENTS AND METHODS: During the years 1996-2016, we performed 2,220 operations in 2,075 patients with a diagnosis of primary hyperparathyroidism. RESULTS: Among these 2,220 operations, there were 16 operations for parathyroid carcinoma. These 16 operations, including reoperations, were performed in four patients. Two patients had no reoperation, but another 2 patients required 14 reoperations in total. Parathyroid carcinoma was described in 0.2% of all patients with a diagnosis of primary hyperparathyroidism. The number of operations was 0.73% of all operations of primary hyperparathyroidism in years 1996-2016. CONCLUSION: Prognosis of parathyroid carcinoma is quite favourable, patients evidence a long-term survival rate after the primary operation. However, every reoperation increases the number of possible complications, including recurrent laryngeal nerve injury. Copyright
Authors: Randall P Owen; Carl E Silver; Phillip K Pellitteri; Ashok R Shaha; Kenneth O Devaney; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito Journal: Head Neck Date: 2011-03 Impact factor: 3.147
Authors: J D Carpten; C M Robbins; A Villablanca; L Forsberg; S Presciuttini; J Bailey-Wilson; W F Simonds; E M Gillanders; A M Kennedy; J D Chen; S K Agarwal; R Sood; M P Jones; T Y Moses; C Haven; D Petillo; P D Leotlela; B Harding; D Cameron; A A Pannett; A Höög; H Heath; L A James-Newton; B Robinson; R J Zarbo; B M Cavaco; W Wassif; N D Perrier; I B Rosen; U Kristoffersson; P D Turnpenny; L-O Farnebo; G M Besser; C E Jackson; H Morreau; J M Trent; R V Thakker; S J Marx; B T Teh; C Larsson; M R Hobbs Journal: Nat Genet Date: 2002-11-18 Impact factor: 38.330
Authors: Loredana De Pasquale; Antonio Mario Bulfamante; Giovanni Felisati; Luca Castellani; Giorgio Ghilardi; Alberto Maria Saibene Journal: Int J Endocrinol Date: 2021-10-07 Impact factor: 3.257
Authors: Diani Kartini; Ahmad Kurnia; Erwin Danil Yulian; Sonar Soni Panigoro; I Gusti Ngurah Gunawan Wibisana; Jessica Wardana Journal: Int J Surg Case Rep Date: 2022-07-09
Authors: Shravan Leonard-Murali; Tommy Ivanics; David S Kwon; Xiaoxia Han; Christopher P Steffes; Rupen Shah Journal: Eur J Surg Oncol Date: 2021-06-27 Impact factor: 4.424